You are here

  • Home
  • Archive
  • Volume 6, Issue 2
  • Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis

Article metrics

Article menu

Download PDFPDF

Psoriatic arthritis
Original research
Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

AbstractFullPdf
Jul 202027027467
Aug 202014113939
Sep 2020544914
Oct 2020383511
Nov 202028287
Dec 2020333110
Jan 2021615521
Feb 2021403429
Mar 2021373613
Apr 2021272523
May 2021181712
Jun 2021373712
Jul 2021373727
Aug 2021363618
Sep 2021272516
Oct 2021323233
Nov 2021161616
Dec 202114136
Jan 202213125
Feb 202219205
Mar 2022373914
Apr 202221175
May 2022495219
Jun 202240399
Jul 202223259
Aug 202245469
Sep 2022464616
Oct 202235366
Nov 202228279
Dec 202217178
Jan 2023394117
Feb 2023505010
Mar 2023313214
Apr 202342425
May 2023434118
Jun 202329293
Jul 202325258
Aug 202314143
Sep 2023201913
Oct 202320209
Nov 2023222213
Dec 2023535316
Jan 202428274
Feb 202416165
Mar 2024222229
Total17731748655